<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/" xmlns:content="http://purl.org/rss/1.0/modules/content/">
  <channel>
    <title>Carlat Podcast</title>
    <description></description>
    <link>https://www.thecarlatreport.com/rss</link>
    <language>en-us</language>
    <item>
      <title>Psychedelics and Addiction Psychiatry</title>
      <description>Today, we'll be talking about psychedelics and addiction psychiatry, what they are, how they work, and what the research actually tells us.</description>
      <content:encoded>
        <![CDATA[<style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p><div style="caret-color: rgb(0, 0, 0); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; widows: auto; word-spacing: 0px; text-align: left;">Today, we'll be talking about psychedelics and addiction psychiatry, what they are, how they work, and what the research actually tells us.&nbsp;</div><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p>]]>
      </content:encoded>
      <guid>http://www.thecarlatreport.com/blogs/2/post/5562</guid>
      <pubDate>Mon, 13 Oct 2025 02:00:48 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/5562-psychedelics-and-addiction-psychiatry</link>
      <media:content url="https://www.thecarlatreport.com/ext/resources/2025/10/12/shutterstock_2689265667.webp?t=1760336374" type="image/jpeg" medium="image" fileSize="339768">
        <media:title type="plain">shutterstock_2689265667.jpg</media:title>
        <media:description type="plain">an abstract illustration of a human brain with colorful neural pathways or light trails (symbolizing psychedelic effects on the mind)</media:description>
      </media:content>
    </item>
    <item>
      <title>The Rise of Long-Acting Buprenorphine</title>
      <description>There are two variations of long-acting injectable buprenorphine on the market. But what differentiates them, who might benefit, and how well do they work? Find out in today’s podcast.</description>
      <content:encoded>
        <![CDATA[<style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><p style="box-sizing: border-box; cursor: text; caret-color: rgb(108, 117, 125); font-style: normal; font-weight: 400; letter-spacing: normal; orphans: auto; text-align: left; widows: auto; word-spacing: 0px;"><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style>There are two variations of long-acting injectable buprenorphine on the market. But what differentiates them, who might benefit, and how well do they work? Find out in today’s podcast.<style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style><style type="text/css">
p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; font: 12.0px Helvetica; color: #000000}
</style></p>]]>
      </content:encoded>
      <guid>http://www.thecarlatreport.com/blogs/2/post/5544</guid>
      <pubDate>Mon, 29 Sep 2025 02:00:48 -0400</pubDate>
      <link>https://www.thecarlatreport.com/blogs/2-the-carlat-psychiatry-podcast/post/5544-the-rise-of-long-acting-buprenorphine</link>
      <media:content url="https://www.thecarlatreport.com/ext/resources/2025/09/28/shutterstock_2683817953.webp?t=1759125755" type="image/jpeg" medium="image" fileSize="104174">
        <media:title type="plain">shutterstock_2683817953.jpg</media:title>
        <media:description type="plain">A split-screen design: left side shows a syringe labeled "Sublocade", right side shows a syringe labeled "Brixadi" ( no medical dosing)</media:description>
      </media:content>
    </item>
  </channel>
</rss>
